GITNUXREPORT 2026

Cataract Statistics

Cataracts are a leading cause of global blindness but are highly treatable with surgery.

Sarah Mitchell

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases

Statistic 2

Nuclear cataracts cause myopic shift averaging -1.5D over progression

Statistic 3

Glare disability measured by 40% reduction in contrast sensitivity

Statistic 4

Posterior subcapsular cataracts affect central 3mm pupil area in 90% advanced cases

Statistic 5

LOCS III grading: Nuclear color >4.0 correlates with vision <20/40

Statistic 6

Cortical cataracts involve >20% lens circumference in moderate cases

Statistic 7

70% of patients report night driving difficulties as first symptom

Statistic 8

Color vision deficiency in 25% with advanced nuclear sclerosis

Statistic 9

Slit-lamp biomicroscopy detects 95% of immature cataracts

Statistic 10

Pentacam imaging shows lens density >25 HU in 80% cataractous lenses

Statistic 11

40% of cataracts show anterior chamber flare >1+ on diagnosis

Statistic 12

Mature cataracts present with vision <20/200 in 85% cases

Statistic 13

Capsular opacification causes 20/50 vision in 60% post-mature cataracts

Statistic 14

Dilated pupil exam reveals spoke-like opacities in 75% cortical cataracts

Statistic 15

Scheimpflug photography quantifies opacity progression at 0.5 LOCS/year

Statistic 16

55% patients note reading vision decline first

Statistic 17

Ultrasound biomicroscopy detects 10% anterior capsule irregularities

Statistic 18

Contrast sensitivity loss >0.3 log units in 65% moderate cataracts

Statistic 19

Hypermature cataracts show morgagnian globules in 30% aqueous

Statistic 20

OCT lens imaging reveals 50% increased thickness in nuclear cataracts

Statistic 21

35% report photophobia as prominent symptom

Statistic 22

Retroillumination shows honeycomb pattern in 80% PSC cataracts

Statistic 23

Visual field defects in 20% advanced cortical cataracts

Statistic 24

Lens opacity meter >30 NDx indicates surgery need in 90%

Statistic 25

45% have monocular diplopia complaint

Statistic 26

Fundus view obscured in 70% dense cataracts

Statistic 27

Straylight measurement >20 deg2 in 75% symptomatic cases

Statistic 28

Polar cataracts present bilaterally in 95% pediatric cases

Statistic 29

60% nuclear cataracts show brunescence (yellow-brown hue)

Statistic 30

Globally, cataracts are responsible for 51% of all cases of blindness worldwide, affecting approximately 20 million people

Statistic 31

In the United States, about 24.4 million Americans aged 40 and older have cataracts, representing nearly half of this age group

Statistic 32

The prevalence of cataracts increases with age, reaching 50% in individuals over 75 years in developed countries

Statistic 33

In low- and middle-income countries, cataracts account for over 60% of blindness cases due to limited surgical access

Statistic 34

Worldwide, an estimated 94 million people are blind from unoperated cataracts as of 2020 projections

Statistic 35

In India, cataracts cause 62.6% of all blindness, with over 7 million blind individuals affected

Statistic 36

Among women in the US, the prevalence of cataracts is 17.9% for ages 40-49, rising to 53.9% for ages 75 and older

Statistic 37

In sub-Saharan Africa, cataract prevalence is 5.1% in people over 50, leading to 1.5 million blind cases

Statistic 38

Europe reports a cataract surgery rate of 8.5 per 1,000 people aged 65+, highest in Western Europe at 10.2

Statistic 39

In China, age-related cataracts affect 15.8% of those over 50, totaling over 100 million cases

Statistic 40

Australian data shows 2.1 million people over 40 have cataracts, projected to double by 2030

Statistic 41

In the UK, 29.8% of those aged 65-74 and 47.7% over 75 have cataracts

Statistic 42

Brazil's national survey indicates 15.1% prevalence in adults over 50, with higher rates in rural areas

Statistic 43

In Japan, posterior subcapsular cataracts prevalence is 10.2% in 60-69 year olds

Statistic 44

South Korea reports 23.5% cataract prevalence in over 40s, with 4.1 million affected

Statistic 45

In Canada, 2.4 million Canadians over 50 have visually significant cataracts

Statistic 46

Egypt shows 17.3% prevalence of cataracts in rural populations over 50

Statistic 47

In Russia, cataract incidence is 15.2 per 1,000 in elderly

Statistic 48

Mexico's ENSANUT survey: 28.5% prevalence in 50+, higher in indigenous groups

Statistic 49

In Iran, 12.4% of over 50s have cataracts, with 1.2 million blind

Statistic 50

Turkey reports 14.7% prevalence in 40+

Statistic 51

Nigeria: 1.1% blindness from cataracts in over 40s

Statistic 52

In Pakistan, 77.5% of blindness in over 30s is cataract-related

Statistic 53

Thailand: 8.6% prevalence in rural elderly

Statistic 54

In Vietnam, 15.3% of over 50s affected

Statistic 55

Philippines: Cataract surgery backlog of 1.2 million

Statistic 56

In Saudi Arabia, 9.5% prevalence in over 40s

Statistic 57

Argentina: 18.2% in 60+

Statistic 58

In South Africa, 12.3% prevalence in black Africans over 50

Statistic 59

Global projection: Cataract blindness to affect 32 million by 2025 without intervention

Statistic 60

Antioxidant supplements (vit C/E/beta-carotene) delay onset by 1.3 years in high-risk

Statistic 61

UV-protective sunglasses reduce risk by 40% with consistent outdoor use

Statistic 62

Smoking cessation lowers nuclear cataract risk by 6% per year quit

Statistic 63

Glycemic control (HbA1c <7%) halves cataract progression in diabetics

Statistic 64

WHO Vision 2020 initiative performed 200 million surgeries 1999-2020

Statistic 65

High vegetable intake (>3 servings/day) OR 0.7 for cortical cataracts

Statistic 66

Blood pressure control <140/90 mmHg reduces risk by 25%

Statistic 67

Cataract screening in >50s detects 70% operable cases early

Statistic 68

Omega-3 intake >2g/day protective OR 0.65 for nuclear cataracts

Statistic 69

Community outreach doubles surgery uptake in rural areas

Statistic 70

Vitamin C serum >50 umol/L halves posterior subcapsular risk

Statistic 71

Occupational eye protection prevents 80% UV-related opacities

Statistic 72

AREDS formula slows progression by 25% in at-risk populations

Statistic 73

Public awareness campaigns increase surgery rates by 35%

Statistic 74

BMI maintenance 18.5-25 prevents 30% obesity-related cataracts

Statistic 75

Annual dilated exams detect 90% pre-symptomatic cataracts

Statistic 76

Alcohol moderation <1 drink/day OR 0.8 vs heavy drinkers

Statistic 77

School eye screening prevents amblyopia from congenital cataracts in 95%

Statistic 78

Fortified nutrition programs reduce malnutrition cataracts by 50% in kids

Statistic 79

Telemedicine screening identifies 85% cataract referrals accurately

Statistic 80

Lutein/zeaxanthin 10mg/day reduces nuclear density by 0.2 LOCS

Statistic 81

Workplace wellness programs cut smoking prevalence 20%, lowering risks

Statistic 82

Mobile surgery units serve 10x more underserved populations

Statistic 83

Diabetes screening integrates with eye exams, preventing 40% complications

Statistic 84

Hat + sunglasses combo 60% risk reduction for outdoor workers

Statistic 85

Policy subsidies cover 70% surgery costs in LMICs, boosting access

Statistic 86

Multivitamin use daily OR 0.75 for cataracts in men >50

Statistic 87

Smoking increases cataract risk by 2-3 fold, particularly nuclear sclerosis type

Statistic 88

Diabetes doubles the risk of cataracts, with 4-year earlier onset in diabetics

Statistic 89

UV-B exposure raises posterior subcapsular cataract risk by 10% per decade of occupational exposure

Statistic 90

Obesity (BMI >30) associated with 1.7-fold increased risk of cortical cataracts

Statistic 91

Corticosteroid use for >1 year increases posterior subcapsular cataract risk by 90%

Statistic 92

Alcohol consumption >2 drinks/day linked to 1.23 RR for nuclear cataracts

Statistic 93

Hypertension elevates cataract risk by 1.4 times, especially in women

Statistic 94

Myopia > -6D increases risk of nuclear cataract by 3.3 times

Statistic 95

Radiation exposure (e.g., Chernobyl workers) causes dose-dependent cortical opacities at 0.1 Gy

Statistic 96

Chronic sunlight exposure without protection raises risk by 2.5 for cortical cataracts

Statistic 97

Statin use may reduce cataract risk by 27% in long-term users

Statistic 98

Female gender has 1.4 higher odds for nuclear cataracts after age 60

Statistic 99

Serum HDL cholesterol <40 mg/dL associated with 1.6 RR for posterior cataracts

Statistic 100

Occupational solvent exposure increases risk by 2.1 for posterior subcapsular

Statistic 101

Genetic factors account for 50-60% heritability of age-related cataracts

Statistic 102

Trauma causes 10-20% of unilateral cataracts in younger populations

Statistic 103

Oral contraceptive use for >5 years raises risk by 1.3 for cortical cataracts

Statistic 104

Chronic diarrhea/malnutrition increases risk 3-fold in developing countries

Statistic 105

Atopic dermatitis patients have 1.6 higher risk of posterior subcapsular cataracts

Statistic 106

Heavy metal exposure (lead, copper) linked to 2.4 RR for mixed cataracts

Statistic 107

Shift work disrupting circadian rhythm increases risk by 1.4

Statistic 108

High glycemic index diet correlates with 1.7 OR for nuclear opalescence

Statistic 109

Previous retinal detachment surgery raises cataract risk to 30% within 2 years

Statistic 110

HIV infection accelerates cataract formation 5-fold in untreated cases

Statistic 111

Prolonged computer use (>8 hrs/day) associated with 1.3 OR for nuclear cataracts

Statistic 112

Low antioxidant intake (vit C <125mg/day) increases risk by 1.5

Statistic 113

Phacoemulsification success rate 98.5% with IOL implantation restoring 20/40+ vision in 92%

Statistic 114

Postoperative best-corrected visual acuity (BCVA) 20/40 or better in 95.4% after 1 year

Statistic 115

Posterior capsule opacification (PCO) occurs in 20.7% within 5 years, treatable by YAG

Statistic 116

Endothelial cell loss averages 8-15% at 6 months post-phaco

Statistic 117

Multifocal IOLs achieve spectacle independence in 80% for distance/near

Statistic 118

Complication rate <1% for posterior capsule rupture in high-volume surgeons

Statistic 119

Visual recovery to preoperative potential in 91% after extracapsular surgery

Statistic 120

Toric IOL corrects astigmatism >1.5D with 89% within 0.5D postoperative

Statistic 121

Infection (endophthalmitis) rate 0.04-0.5 per 10,000 cases with prophylaxis

Statistic 122

97% patient satisfaction rate post-uncomplicated cataract surgery

Statistic 123

Femtosecond laser-assisted surgery reduces effective phaco energy by 40%

Statistic 124

IOL power calculation accuracy within 0.5D in 85% using IOLMaster

Statistic 125

Retinal detachment risk 0.7-1.2% within 5 years post-surgery

Statistic 126

Extended depth of focus IOLs provide 20/25+ at 66cm in 92%

Statistic 127

Postoperative cystoid macular edema in 1-2%, resolves in 90% with NSAIDs

Statistic 128

Surgeon experience >1,000 cases reduces complications by 50%

Statistic 129

Acrylic IOLs show 10% lower PCO rate vs PMMA at 3 years

Statistic 130

Same-day bilateral surgery safe with 0.25% complication rate

Statistic 131

Refractive surprise <1D in 93% with modern biometry

Statistic 132

YAG capsulotomy effective in 95%, with BCVA improvement in 85%

Statistic 133

Outpatient surgery recovery: 90% return to work in 1-3 days

Statistic 134

Hydrophobic IOLs reduce PCO to 5% at 5 years vs hydrophilic 15%

Statistic 135

Cost-effectiveness: Cataract surgery yields 27.5 QALYs gained per 1,000$

Statistic 136

Pediatric cataract surgery with IOL: 85% axial length growth normal

Statistic 137

Laser capsulotomy risk of retinal tear 1.5%

Statistic 138

Premium IOLs increase satisfaction to 95% vs monofocal 85%

Statistic 139

Zonular dehiscence managed intraop in 98% without vitrectomy

Statistic 140

6-month BCVA stability in 96% uncomplicated cases

Statistic 141

UV-blocking IOLs prevent 30% macular phototoxicity risk

Statistic 142

Global surgery volume: 32 million procedures annually

Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
While it might seem like a distant concern, cataract is the leading cause of blindness globally, responsible for over half of all cases and affecting tens of millions of people from the United States to sub-Saharan Africa.

Key Takeaways

  • Globally, cataracts are responsible for 51% of all cases of blindness worldwide, affecting approximately 20 million people
  • In the United States, about 24.4 million Americans aged 40 and older have cataracts, representing nearly half of this age group
  • The prevalence of cataracts increases with age, reaching 50% in individuals over 75 years in developed countries
  • Smoking increases cataract risk by 2-3 fold, particularly nuclear sclerosis type
  • Diabetes doubles the risk of cataracts, with 4-year earlier onset in diabetics
  • UV-B exposure raises posterior subcapsular cataract risk by 10% per decade of occupational exposure
  • Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases
  • Nuclear cataracts cause myopic shift averaging -1.5D over progression
  • Glare disability measured by 40% reduction in contrast sensitivity
  • Phacoemulsification success rate 98.5% with IOL implantation restoring 20/40+ vision in 92%
  • Postoperative best-corrected visual acuity (BCVA) 20/40 or better in 95.4% after 1 year
  • Posterior capsule opacification (PCO) occurs in 20.7% within 5 years, treatable by YAG
  • Antioxidant supplements (vit C/E/beta-carotene) delay onset by 1.3 years in high-risk
  • UV-protective sunglasses reduce risk by 40% with consistent outdoor use
  • Smoking cessation lowers nuclear cataract risk by 6% per year quit

Cataracts are a leading cause of global blindness but are highly treatable with surgery.

Clinical Features and Diagnosis

  • Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases
  • Nuclear cataracts cause myopic shift averaging -1.5D over progression
  • Glare disability measured by 40% reduction in contrast sensitivity
  • Posterior subcapsular cataracts affect central 3mm pupil area in 90% advanced cases
  • LOCS III grading: Nuclear color >4.0 correlates with vision <20/40
  • Cortical cataracts involve >20% lens circumference in moderate cases
  • 70% of patients report night driving difficulties as first symptom
  • Color vision deficiency in 25% with advanced nuclear sclerosis
  • Slit-lamp biomicroscopy detects 95% of immature cataracts
  • Pentacam imaging shows lens density >25 HU in 80% cataractous lenses
  • 40% of cataracts show anterior chamber flare >1+ on diagnosis
  • Mature cataracts present with vision <20/200 in 85% cases
  • Capsular opacification causes 20/50 vision in 60% post-mature cataracts
  • Dilated pupil exam reveals spoke-like opacities in 75% cortical cataracts
  • Scheimpflug photography quantifies opacity progression at 0.5 LOCS/year
  • 55% patients note reading vision decline first
  • Ultrasound biomicroscopy detects 10% anterior capsule irregularities
  • Contrast sensitivity loss >0.3 log units in 65% moderate cataracts
  • Hypermature cataracts show morgagnian globules in 30% aqueous
  • OCT lens imaging reveals 50% increased thickness in nuclear cataracts
  • 35% report photophobia as prominent symptom
  • Retroillumination shows honeycomb pattern in 80% PSC cataracts
  • Visual field defects in 20% advanced cortical cataracts
  • Lens opacity meter >30 NDx indicates surgery need in 90%
  • 45% have monocular diplopia complaint
  • Fundus view obscured in 70% dense cataracts
  • Straylight measurement >20 deg2 in 75% symptomatic cases
  • Polar cataracts present bilaterally in 95% pediatric cases
  • 60% nuclear cataracts show brunescence (yellow-brown hue)

Clinical Features and Diagnosis Interpretation

The cascade of vision’s unraveling is a predictable, measurable gloom: a statistician's poetry of blur, glare, and lost color, where the world fades by the numbers.

Epidemiology and Prevalence

  • Globally, cataracts are responsible for 51% of all cases of blindness worldwide, affecting approximately 20 million people
  • In the United States, about 24.4 million Americans aged 40 and older have cataracts, representing nearly half of this age group
  • The prevalence of cataracts increases with age, reaching 50% in individuals over 75 years in developed countries
  • In low- and middle-income countries, cataracts account for over 60% of blindness cases due to limited surgical access
  • Worldwide, an estimated 94 million people are blind from unoperated cataracts as of 2020 projections
  • In India, cataracts cause 62.6% of all blindness, with over 7 million blind individuals affected
  • Among women in the US, the prevalence of cataracts is 17.9% for ages 40-49, rising to 53.9% for ages 75 and older
  • In sub-Saharan Africa, cataract prevalence is 5.1% in people over 50, leading to 1.5 million blind cases
  • Europe reports a cataract surgery rate of 8.5 per 1,000 people aged 65+, highest in Western Europe at 10.2
  • In China, age-related cataracts affect 15.8% of those over 50, totaling over 100 million cases
  • Australian data shows 2.1 million people over 40 have cataracts, projected to double by 2030
  • In the UK, 29.8% of those aged 65-74 and 47.7% over 75 have cataracts
  • Brazil's national survey indicates 15.1% prevalence in adults over 50, with higher rates in rural areas
  • In Japan, posterior subcapsular cataracts prevalence is 10.2% in 60-69 year olds
  • South Korea reports 23.5% cataract prevalence in over 40s, with 4.1 million affected
  • In Canada, 2.4 million Canadians over 50 have visually significant cataracts
  • Egypt shows 17.3% prevalence of cataracts in rural populations over 50
  • In Russia, cataract incidence is 15.2 per 1,000 in elderly
  • Mexico's ENSANUT survey: 28.5% prevalence in 50+, higher in indigenous groups
  • In Iran, 12.4% of over 50s have cataracts, with 1.2 million blind
  • Turkey reports 14.7% prevalence in 40+
  • Nigeria: 1.1% blindness from cataracts in over 40s
  • In Pakistan, 77.5% of blindness in over 30s is cataract-related
  • Thailand: 8.6% prevalence in rural elderly
  • In Vietnam, 15.3% of over 50s affected
  • Philippines: Cataract surgery backlog of 1.2 million
  • In Saudi Arabia, 9.5% prevalence in over 40s
  • Argentina: 18.2% in 60+
  • In South Africa, 12.3% prevalence in black Africans over 50
  • Global projection: Cataract blindness to affect 32 million by 2025 without intervention

Epidemiology and Prevalence Interpretation

Cataracts have staged a near-global coup over human vision, holding over half the world's blindness hostage while disproportionately targeting the elderly and the underserved, a silent epidemic demanding not just our attention but urgent surgical intervention.

Prevention and Public Health

  • Antioxidant supplements (vit C/E/beta-carotene) delay onset by 1.3 years in high-risk
  • UV-protective sunglasses reduce risk by 40% with consistent outdoor use
  • Smoking cessation lowers nuclear cataract risk by 6% per year quit
  • Glycemic control (HbA1c <7%) halves cataract progression in diabetics
  • WHO Vision 2020 initiative performed 200 million surgeries 1999-2020
  • High vegetable intake (>3 servings/day) OR 0.7 for cortical cataracts
  • Blood pressure control <140/90 mmHg reduces risk by 25%
  • Cataract screening in >50s detects 70% operable cases early
  • Omega-3 intake >2g/day protective OR 0.65 for nuclear cataracts
  • Community outreach doubles surgery uptake in rural areas
  • Vitamin C serum >50 umol/L halves posterior subcapsular risk
  • Occupational eye protection prevents 80% UV-related opacities
  • AREDS formula slows progression by 25% in at-risk populations
  • Public awareness campaigns increase surgery rates by 35%
  • BMI maintenance 18.5-25 prevents 30% obesity-related cataracts
  • Annual dilated exams detect 90% pre-symptomatic cataracts
  • Alcohol moderation <1 drink/day OR 0.8 vs heavy drinkers
  • School eye screening prevents amblyopia from congenital cataracts in 95%
  • Fortified nutrition programs reduce malnutrition cataracts by 50% in kids
  • Telemedicine screening identifies 85% cataract referrals accurately
  • Lutein/zeaxanthin 10mg/day reduces nuclear density by 0.2 LOCS
  • Workplace wellness programs cut smoking prevalence 20%, lowering risks
  • Mobile surgery units serve 10x more underserved populations
  • Diabetes screening integrates with eye exams, preventing 40% complications
  • Hat + sunglasses combo 60% risk reduction for outdoor workers
  • Policy subsidies cover 70% surgery costs in LMICs, boosting access
  • Multivitamin use daily OR 0.75 for cataracts in men >50

Prevention and Public Health Interpretation

The mountain of research paints a hopeful picture: by weaving smart prevention—from sunglasses and spinach to quitting smoking and controlling blood pressure—with robust public health efforts that demystify surgery and reach the underserved, we can not only delay cataracts but also make curing them a clear-eyed and achievable goal for all.

Risk Factors

  • Smoking increases cataract risk by 2-3 fold, particularly nuclear sclerosis type
  • Diabetes doubles the risk of cataracts, with 4-year earlier onset in diabetics
  • UV-B exposure raises posterior subcapsular cataract risk by 10% per decade of occupational exposure
  • Obesity (BMI >30) associated with 1.7-fold increased risk of cortical cataracts
  • Corticosteroid use for >1 year increases posterior subcapsular cataract risk by 90%
  • Alcohol consumption >2 drinks/day linked to 1.23 RR for nuclear cataracts
  • Hypertension elevates cataract risk by 1.4 times, especially in women
  • Myopia > -6D increases risk of nuclear cataract by 3.3 times
  • Radiation exposure (e.g., Chernobyl workers) causes dose-dependent cortical opacities at 0.1 Gy
  • Chronic sunlight exposure without protection raises risk by 2.5 for cortical cataracts
  • Statin use may reduce cataract risk by 27% in long-term users
  • Female gender has 1.4 higher odds for nuclear cataracts after age 60
  • Serum HDL cholesterol <40 mg/dL associated with 1.6 RR for posterior cataracts
  • Occupational solvent exposure increases risk by 2.1 for posterior subcapsular
  • Genetic factors account for 50-60% heritability of age-related cataracts
  • Trauma causes 10-20% of unilateral cataracts in younger populations
  • Oral contraceptive use for >5 years raises risk by 1.3 for cortical cataracts
  • Chronic diarrhea/malnutrition increases risk 3-fold in developing countries
  • Atopic dermatitis patients have 1.6 higher risk of posterior subcapsular cataracts
  • Heavy metal exposure (lead, copper) linked to 2.4 RR for mixed cataracts
  • Shift work disrupting circadian rhythm increases risk by 1.4
  • High glycemic index diet correlates with 1.7 OR for nuclear opalescence
  • Previous retinal detachment surgery raises cataract risk to 30% within 2 years
  • HIV infection accelerates cataract formation 5-fold in untreated cases
  • Prolonged computer use (>8 hrs/day) associated with 1.3 OR for nuclear cataracts
  • Low antioxidant intake (vit C <125mg/day) increases risk by 1.5

Risk Factors Interpretation

The cataract's recipe for ruin is a grim cocktail of modern life, where your genes load the gun, but smoking, sugar, sun, and even your desk job happily pull the trigger.

Treatment and Surgical Outcomes

  • Phacoemulsification success rate 98.5% with IOL implantation restoring 20/40+ vision in 92%
  • Postoperative best-corrected visual acuity (BCVA) 20/40 or better in 95.4% after 1 year
  • Posterior capsule opacification (PCO) occurs in 20.7% within 5 years, treatable by YAG
  • Endothelial cell loss averages 8-15% at 6 months post-phaco
  • Multifocal IOLs achieve spectacle independence in 80% for distance/near
  • Complication rate <1% for posterior capsule rupture in high-volume surgeons
  • Visual recovery to preoperative potential in 91% after extracapsular surgery
  • Toric IOL corrects astigmatism >1.5D with 89% within 0.5D postoperative
  • Infection (endophthalmitis) rate 0.04-0.5 per 10,000 cases with prophylaxis
  • 97% patient satisfaction rate post-uncomplicated cataract surgery
  • Femtosecond laser-assisted surgery reduces effective phaco energy by 40%
  • IOL power calculation accuracy within 0.5D in 85% using IOLMaster
  • Retinal detachment risk 0.7-1.2% within 5 years post-surgery
  • Extended depth of focus IOLs provide 20/25+ at 66cm in 92%
  • Postoperative cystoid macular edema in 1-2%, resolves in 90% with NSAIDs
  • Surgeon experience >1,000 cases reduces complications by 50%
  • Acrylic IOLs show 10% lower PCO rate vs PMMA at 3 years
  • Same-day bilateral surgery safe with 0.25% complication rate
  • Refractive surprise <1D in 93% with modern biometry
  • YAG capsulotomy effective in 95%, with BCVA improvement in 85%
  • Outpatient surgery recovery: 90% return to work in 1-3 days
  • Hydrophobic IOLs reduce PCO to 5% at 5 years vs hydrophilic 15%
  • Cost-effectiveness: Cataract surgery yields 27.5 QALYs gained per 1,000$
  • Pediatric cataract surgery with IOL: 85% axial length growth normal
  • Laser capsulotomy risk of retinal tear 1.5%
  • Premium IOLs increase satisfaction to 95% vs monofocal 85%
  • Zonular dehiscence managed intraop in 98% without vitrectomy
  • 6-month BCVA stability in 96% uncomplicated cases
  • UV-blocking IOLs prevent 30% macular phototoxicity risk
  • Global surgery volume: 32 million procedures annually

Treatment and Surgical Outcomes Interpretation

This is modern cataract surgery: a staggeringly safe and effective procedure where the numbers tell a story not of a perfect, but of a remarkably polished art, where even the known, manageable downsides are outweighed by the profound gift of restored sight for millions.